@article{article3d3c180c,
title   = {Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial},
author = {Rovin, Brad H and Barratt, Jonathan and Heerspink, Hiddo J. L. and Alpers, Charles E. and Bieler, Stewart and Chae, Dong-Wan and Diva, Ulysses A. and Floege, Juergen and Gesualdo, Loreto and Inrig, Jula K. and Noronha, Irene de Lourdes},
year = {2023},
doi = {10.1016/S0140-6736(23)02302-4},
journal   = {LANCET}
}